SCHEDULE: Vanguard Group Reports 0% Stake in Oscar Health

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Oscar Health Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 5 to its Schedule 13G for Oscar Health Inc.
• The filing reports 0% beneficial ownership of Oscar Health Inc. common stock by The Vanguard Group.
• This change is due to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral for Oscar Health Inc. as it primarily reflects a technical reporting change by The Vanguard Group rather than a fundamental shift in investment strategy or a complete divestment by all Vanguard-managed funds.

Positives

• The filing clarifies the reporting structure for Vanguard's beneficial ownership, aligning with SEC guidance for internal realignments.

Negatives

• The Vanguard Group, as the primary reporting entity, no longer holds a direct beneficial ownership stake in Oscar Health Inc. as per this filing.

Risks

• There is a potential risk of misinterpreting the 0% beneficial ownership reported by The Vanguard Group, Inc. as a complete divestment by all Vanguard-managed funds, rather than a technical change in reporting structure where subsidiaries will now report separately.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Oscar Health Inc.'s future performance or The Vanguard Group's overall investment strategy beyond the reporting realignment.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment."
• "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that large institutional investors like The Vanguard Group frequently undergo internal restructurings or re-evaluate their reporting methodologies to comply with evolving regulatory guidance. This disaggregation of reporting is a technical compliance matter rather than a strategic investment decision regarding Oscar Health Inc.

Stakeholder Impact

• Shareholders of Oscar Health Inc. should understand that the 0% reported by The Vanguard Group, Inc. does not necessarily mean all Vanguard-managed funds have divested, but rather that reporting has been disaggregated to other Vanguard entities.

Next Steps

• Future Schedule 13G filings for Oscar Health Inc. will likely come from specific Vanguard subsidiaries or business divisions, reporting their individual beneficial ownership stakes.

Key Dates

Recommendation

The filing indicates a technical change in how The Vanguard Group reports its beneficial ownership, not a strategic divestment from Oscar Health Inc. While the parent entity now reports 0% ownership, the underlying investment strategies by its subsidiaries remain the same. Therefore, this filing alone does not warrant a change in investment thesis for Oscar Health Inc., suggesting a 'hold' position for existing investors.

Keywords

Oscar Health, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, Realignment